Hey again, as I had suggested in my last post, RNXT proved its growth in the recent earnings by miles. There is still way more potential here as the application for Renovo is now also going beyond Pancreatic cancer.
How do I know? I work as an RN at the only hospital in one of the largest healthcare systems doing the Renovo procedure and our patient list is growing with positive procedure outcomes. This procedure also needs to happen multiple times which means more money for the hospitals and eventual need for surgery making it a very attractive option for healthcare systems to invest in. Eventually our patient list will be too long and other facilities will catch on so now is still the perfect time to invest.
TLDR; less cancer, more money